Cara Starnbach

PhD student @StevenMBanik Lab || former TPD enthusiast in @SBuhrlage and Nathanael Gray labs || @BatesCollege B.S. ‘19 @JenKoviachCote Lab

[Steven Banik @StevenMBanik]

Excited our ratiometric transcriptional activation (RTA) work led by @Melissa_Gray234 is out online today @CellCellPress! Measurements determine what we can discover in biology; we use RTA to turn protein abundance changes into amplified signals.

https://t.co/3rRhr2pjhu

[Steven Banik @StevenMBanik]

Excited to share our latest preprint on work led by postdoc Robert Lusi (@noScandineHere)! Introducing ALTER (AGO-Led Targeted Editing of RNA) for non-downregulatory RNA manipulation by repurposing hAGO2, non-immunogenic and capitalizing on evolution. https://t.co/wJa7XIiqwX

[Steven Banik @StevenMBanik]

Incredibly proud of @tineisadora for defending her PhD work today (the first Banik lab PhD!). So lucky to have been a part of her journey!

[Christine Isadora Ng @tineisadora]

Honored to receive the Women in TPD & Induced Proximity Initiative Scholarship to attend the upcoming Keystone Proximity-Based Therapeutics conference! Grateful for initiatives that support and amplify women in science 🙌  Excited to connect and learn!

[Steven Banik @StevenMBanik]

Excited our final version of @tineisadora's work on targeted protein relocalization is out today @nature! Molecular control over protein localization could offer new opportunities for therapeutics and biological discovery. @Stanford_ChEMH @StanfordUChem https://t.co/XQFwRmnfaX

[Bailey Schultz @bjschul7]

just saw a marathon sign that said, “You didn’t have to run 26.2 miles just to get out of tissue culture,” and honestly i love boston sometimes

[Steven Banik @StevenMBanik]

Excited to share this work from @tineisadora! Precise control over protein subcellular localization could have massive implications for gain-of-function therapeutic strategies. We showcase targeted relocalization activating molecules (TRAMs) for rewiring interactomes. (1/n)

[Behnam Nabet @behnamnabet]

So proud to share my lab’s first PROTAC in @ChemBioChem #ChemBioTalents! In work led by @ErikoKoide & Kaela Mohardt, we developed a selective in vivo-compatible FAK inhibitor and PROTAC with exciting activity in pancreatic cancer models. A few highlights:

https://t.co/SKAgkHKJG0

[Mikaela Ribi @MikaelaRibi]

Thank you for the amazing support! @Stanford_ChEMH

[Cara Starnbach @CStarnbach]

@fischerlab1 @noah_krupnick Go @noah_krupnick !!!!! Congratulations 🥳

[Laura Doherty @LauraDohertyM]

So exciting to see my graduate work published! Thank you to everyone who made this paper possible! @cthoyt @benjamingyori @HiTSatHarvard @DFCI_ChemBio

Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes https://t.co/9wyswADgCL

[Nature Chemical Biology @nchembio]

A new paper from Jack Taunton and colleagues developed salicylaldehyde-based chemical probes that reversibly and covalently modify the catalytic lysine of protein kinases, with sustained occupancy in cells and animals. Free to read: https://t.co/yDviFO3J3v https://t.co/4deMHTFmwv

[Behnam Nabet @behnamnabet]

Milestone day for our team!! Check out our lab's first paper @fredhutch disclosing our CDK11 inhibitor! In work led by @ZhengnianLi and Ryosuke Ishida, we developed a new chemical probe (ZNL-05-044) for studying this fascinating understudied CDK. https://t.co/vDqTEEjkVR

[Behnam Nabet @behnamnabet]

The Nabet lab @fredhutch is hiring! We are seeking a curious and highly motivated Research Technician to join our growing team and have exciting projects aimed at advancing new targeted protein degradation technologies. Please RT and apply here:
https://t.co/VQv28sv8LT

[Cara Starnbach @CStarnbach]

@NaOHBartfield I’m crying in the club 🐅🐅🐅

[Cara Starnbach @CStarnbach]

@NaOHBartfield Yessssss

[NaOH Bartfield, PhD 🧪 @NaOHBartfield]

burrow time

[NFL @NFL]

lol